2nd UPDATE: AstraZeneca 2013 Results Down, Guidance Lowered
LONDON (Alliance News) - AstraZeneca PLC lowered its full-year forecast Thursday, as it saw revenue and pretax profit decline in the full year ended December 31, 2013, due to the loss of exclusivity on several of its brands and increased competition from generics. The pharmaceutical giant p Read More